Hubert Birner, Ph.D.
Managing Partner, TVM Capital
Hubert Birner, Ph.D., joined TVM Capital in 2000, and is responsible for TVM Capital Life Sciences’ overall investment strategy and the fund operations in North America and Europe. He currently serves as Chairman of the Board of Argos Therapeutics Inc. (Durham, North Carolina) and Spepharm Holding BV (Amsterdam, The Netherlands). Before joining TVM Capital, he was Head of Business Development Europe and Director of Marketing for Germany at Zeneca. Dr. Birner joined Zeneca from McKinsey & Company’s European Health Care and Pharmaceutical practice. Dr. Birner was also an Assistant Professor for biochemistry at the Ludwig-Maximilian-University in Munich. In this capacity, he directed various research projects for large pharmaceutical companies. Dr. Birner holds an M.B.A. from Harvard Business School and a doctoral degree in biochemistry from Ludwig-Maximilian-University Munich, where he graduated summa cum laude. His doctoral thesis was honored with the Hoffmann-La Roche prize for outstanding basic research in metabolic diseases.